Skip to content

Combining metabolomics and fNIRS to study the mechanism of Taijiquan on upper limb functional rehabilitation after stroke

Combining metabolomics and fNIRS to study the mechanism of Taijiquan on upper limb functional rehabilitation after stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085284
Enrollment
Unknown
Registered
2024-06-04
Start date
2022-07-06
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper limb dysfunction after stroke

Interventions

Control Group:Conventional rehabilitation, with no other intervention, lasted for four weeks
Experimental group:On the basis of conventional treatment, Tai Chi upper limb rehabilitation exercise intervention was applied for 30 minutes a day, five days a week for four weeks

Sponsors

Panyu Central Hospital, Panyu District, Guangzhou City, Guangdong Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The inclusion criteria and exclusion criteria were all upper limb motor dysfunction according to the criteria of the completed study on the three-level rehabilitation treatment program of cerebrovascular disease in the National Fifteenth Scientific and Technological Research topic. 2. 3. Muscle tone below grade II; 4. After the onset of stroke, the vital signs began smoothly until within six months after the onset of stroke; 5. Sitting balance reaches level 2 or above; 6. No serious cognitive dysfunction, clear mind, able to communicate effectively; 7. Informed consent and can cooperate with treatment, care and examination;

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. Patients with serious diseases, such as severe coronary heart disease, hypertension, poorly controlled diabetes, liver and kidney insufficiency, and malignant tumors; 3. Accompanied by moderate to severe cognitive understanding or visual impairment; 4. Previous neuromuscular disease or motor dysfunction not caused by stroke; 5. Those who have participated in any clinical trial other than this study; 6. Other reasons that the doctor thinks may affect the conduct of clinical research;

Design outcomes

Primary

MeasureTime frame
Serum metabolite content;

Secondary

MeasureTime frame
Cerebral cortex hemoglobin concentration;Indicators of upper limb function;

Countries

China

Contacts

Public ContactKaifeng Guo

Panyu Central Hospital, Panyu District, Guangzhou City, Guangdong Province

624735306@QQ.com+86 188 2504 5821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026